Concepedia

Publication | Open Access

Multi-Institutional Experience with FOLFIRINOX in Pancreatic Adenocarcinoma

112

Citations

9

References

2012

Year

Abstract

Despite substantial rates of adverse events and use of dose modifications, FOLFIRINOX was found to be clinically effective in both metastatic and non-metastatic patients. Regimen toxicity did not detract from overall response and survival.

References

YearCitations

Page 1